XML 25 R10.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jul. 26, 2025
Jul. 27, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 56,380 $ 50,462
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 36,654 35,461
Non-cash share-based compensation 3,406 3,993
Non-cash pension settlement gain (859) 0
Deferred taxes 3,510 (170)
Provision to value inventories at LIFO 593 551
Impairment of assets 1,462 2,125
Gain on sale of assets (2) (233)
Changes in assets and liabilities:    
Merchandise inventories (5,278) (2,775)
Patronage dividend receivable 1,924 (3,602)
Accounts payable to Wakefern 1,834 1,690
Accounts payable and accrued expenses 1,888 (1,209)
Accrued wages and benefits (485) 2,636
Income taxes receivable / payable (2,771) (11,760)
Other assets and liabilities (5,034) 3,680
Net cash provided by operating activities 93,222 80,849
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (58,765) (63,113)
Proceeds from the sale of assets 2 233
Investment in notes receivable from Wakefern (8,343) (41,991)
Investment in real estate partnerships (339) (6,480)
Maturity of notes receivable from Wakefern 0 33,338
Acquisition of lease right-of-use assets (8,133) 0
Net cash used in investing activities (75,578) (78,013)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from exercise of stock options 53 45
Excess tax benefit related to share-based compensation 55 25
Principal payments of long-term debt (11,006) (11,003)
Dividends (13,308) (13,341)
Treasury stock purchases, including shares surrendered for withholding taxes 0 (2,211)
Net cash used in financing activities (24,206) (26,485)
NET DECREASE IN CASH AND CASH EQUIVALENTS (6,562) (23,649)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 117,261 140,910
CASH AND CASH EQUIVALENTS, END OF YEAR 110,699 117,261
SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR:    
Interest 3,751 4,135
Income taxes 24,695 34,160
Investment in Wakefern and increase in notes payable to Wakefern 0 31
Capital expenditures included in accounts payable and accrued expenses $ 9,350 $ 5,972